IN2014DN10683A - - Google Patents
Info
- Publication number
- IN2014DN10683A IN2014DN10683A IN10683DEN2014A IN2014DN10683A IN 2014DN10683 A IN2014DN10683 A IN 2014DN10683A IN 10683DEN2014 A IN10683DEN2014 A IN 10683DEN2014A IN 2014DN10683 A IN2014DN10683 A IN 2014DN10683A
- Authority
- IN
- India
- Prior art keywords
- dopyridine
- benzylcarbami
- prevention
- methyl
- compound
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
The present application relates to a new salt of N-methyl-4-benzylcarbami- dopyridine, a process for its preparation, a pharmaceutical composition comprising this compound and its use for the treatment or prevention of viral diseases.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EP2012/059258 WO2013170901A1 (en) | 2012-05-18 | 2012-05-18 | N-methyl-4-benzylcarbamidopyridinium chloride and a process for its preparation |
PCT/EP2013/060158 WO2013171307A1 (en) | 2012-05-18 | 2013-05-16 | N-methyl-4-benzylcarbamidopyridinium chloride and a process for its preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014DN10683A true IN2014DN10683A (en) | 2015-08-28 |
Family
ID=48483057
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN10683DEN2014 IN2014DN10683A (en) | 2012-05-18 | 2013-05-16 |
Country Status (12)
Country | Link |
---|---|
US (2) | US9493416B2 (en) |
EP (1) | EP2850063B1 (en) |
JP (1) | JP2015517513A (en) |
KR (1) | KR101777561B1 (en) |
BR (1) | BR112014028576B1 (en) |
CA (1) | CA2873977C (en) |
EA (1) | EA025409B1 (en) |
ES (1) | ES2573286T3 (en) |
IN (1) | IN2014DN10683A (en) |
PL (1) | PL2850063T3 (en) |
UA (1) | UA110889C2 (en) |
WO (2) | WO2013170901A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2689775C1 (en) * | 2018-11-02 | 2019-05-29 | Открытое акционерное общество "Авексима" | Industrial production of n-methyl-4-benzylcarbamidopyridinium iodide |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU58612A1 (en) | 1939-10-29 | 1939-11-30 | П.С. Мордовин | Device for connecting two-subscriber devices to one station line |
SU548612A1 (en) | 1975-07-18 | 1977-02-28 | Казанский Химико-Технологический Институт Им.С.М.Кирова | Method for preparing 10-chlorophenoxarsine |
US4115390A (en) * | 1977-08-19 | 1978-09-19 | Nardi John C | Method for the preparation of 1-alkyl pyridinium chlorides |
ATE194983T1 (en) * | 1992-06-04 | 2000-08-15 | Micro Flo Co | MEPIQUATCHLORIDE COVERED WITH A WATER SOLUBLE POLYMER |
WO2011158058A1 (en) | 2010-06-17 | 2011-12-22 | Farmak International Holding Gmbh | α-CRYSTALLINE FORM OF CARBABENZPYRIDE |
-
2012
- 2012-05-18 UA UAA201412193A patent/UA110889C2/en unknown
- 2012-05-18 WO PCT/EP2012/059258 patent/WO2013170901A1/en active Application Filing
-
2013
- 2013-05-16 EP EP13724564.3A patent/EP2850063B1/en active Active
- 2013-05-16 KR KR1020147028207A patent/KR101777561B1/en active Active
- 2013-05-16 US US14/368,505 patent/US9493416B2/en active Active
- 2013-05-16 BR BR112014028576-4A patent/BR112014028576B1/en not_active IP Right Cessation
- 2013-05-16 ES ES13724564.3T patent/ES2573286T3/en active Active
- 2013-05-16 CA CA2873977A patent/CA2873977C/en not_active Expired - Fee Related
- 2013-05-16 JP JP2015512063A patent/JP2015517513A/en active Pending
- 2013-05-16 IN IN10683DEN2014 patent/IN2014DN10683A/en unknown
- 2013-05-16 EA EA201492161A patent/EA025409B1/en not_active IP Right Cessation
- 2013-05-16 PL PL13724564.3T patent/PL2850063T3/en unknown
- 2013-05-16 WO PCT/EP2013/060158 patent/WO2013171307A1/en active Application Filing
-
2016
- 2016-10-20 US US15/298,400 patent/US20170037011A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
UA110889C2 (en) | 2016-02-25 |
WO2013171307A1 (en) | 2013-11-21 |
US20170037011A1 (en) | 2017-02-09 |
KR20150013124A (en) | 2015-02-04 |
BR112014028576A2 (en) | 2017-06-27 |
EP2850063A1 (en) | 2015-03-25 |
EA025409B1 (en) | 2016-12-30 |
BR112014028576B1 (en) | 2020-11-03 |
EP2850063B1 (en) | 2016-04-13 |
US20140357677A1 (en) | 2014-12-04 |
ES2573286T3 (en) | 2016-06-07 |
CN104321312A (en) | 2015-01-28 |
KR101777561B1 (en) | 2017-09-12 |
PL2850063T3 (en) | 2016-10-31 |
US9493416B2 (en) | 2016-11-15 |
CA2873977A1 (en) | 2013-11-21 |
JP2015517513A (en) | 2015-06-22 |
EA201492161A1 (en) | 2015-03-31 |
CA2873977C (en) | 2019-09-17 |
WO2013170901A1 (en) | 2013-11-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12015500274B1 (en) | Alkylpyrimidine derivatives for the treatment of viral infections and further diseases | |
GB201118656D0 (en) | New compounds | |
MX349004B (en) | New compounds. | |
GB201209613D0 (en) | New compounds | |
TN2015000278A1 (en) | Autotaxin inhibitors | |
PH12014501702A1 (en) | Imidazopyrrolidinone compounds | |
PH12014501738A1 (en) | Piperidino-pyrimidine derivatives for the treatment of viral infections | |
MD4589B1 (en) | Pharmaceutical composition comprising sofosbuvir and uses thereof for treating hepatitis C virus | |
PH12015500713A1 (en) | Acylaminopyrimidine derivatives for the treatment of viral infections and further diseases | |
MX366899B (en) | New compounds. | |
MX355267B (en) | 2'- substituted carba-nucleoside analogs for antiviral treatment. | |
IN2014MN00986A (en) | ||
MX2013012053A (en) | Inhibitors of viral replication, their process of preparation and their therapeutical uses. | |
ZA201308617B (en) | Use of thiazolide compounds for the prevention and treatment of viral diseases, cancer and diseases caused by intracellular infections | |
MX2015007916A (en) | Peri-carbinols. | |
MX2014010433A (en) | Novel crystalline form of sitagliptin sulfate. | |
MX2015003034A (en) | Syringe containing a composition, especially a pharmaceutical composition, comprising immunoglobins, method for the production thereof and use of same. | |
NZ707773A (en) | Methods of treating liver diseases | |
IN2014DN03010A (en) | ||
IN2013MU03118A (en) | ||
TN2015000095A1 (en) | Macrolide derivatives, preparation thereof and therapeutic use thereof | |
IN2014DN10683A (en) | ||
PH12015502703A1 (en) | Pharmaceutical compositions | |
IN2014DN07897A (en) | ||
MX2013002446A (en) | Substituted tetrahydropyrrolopyrazine derivatives. |